Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The impact of a massive spike in GLP-1 adoption in 2025 goes well beyond food
This marks the first time a biosimilar of liraglutide has been introduced in India, following approval from the Drug Controller General of India (DCGI)
It will be a useful resource for clinicians and researchers seeking an integrated translational view of how GLP-1RAs may both protect and, under certain clinical circumstances, be associated with ocular adverse events, while emphasizing the need for further mechanistic and long-term outcome data
The vial lasts 10 weeks
US$ 26.43
US$ 29.53
US$ 26.58
US$ 22.83
